Trial intelligence / Profile preview

Antiviral Treatment in Facial Palsy

NCT02328079Completed

Sponsor
Assiut University
Start
Apr 2013
Primary completion
Nov 2014
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Randomised, open-label trial of aciclovir in facial palsy (2 arms), sponsored by Assiut University. Primary endpoint: Facial muscle function using clinical scale at 2 months. Started Apr 2013; status: completed.

02

Drugs

aciclovir
03

Conditions

facial palsy

Beyond the preview

Go deeper on NCT02328079.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02328079.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call